INCOME TAXES (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| INCOME TAXES |
|
| Schedule of U.S. and foreign loss before income taxes |
| | | | | | | | | 2025 | | 2024 | United States | | $ | (15,722,913) | | $ | (8,962,472) | Foreign | | | (81,742) | | | — | Income before income taxes | | $ | (15,804,655) | | $ | (8,962,472) |
|
| Schedule of reconciliation between effective tax and tax computed by applying the U.S. federal income tax rate |
| | | | | | | | | Year Ended December 31, 2025 | | Book earnings (loss) before taxes | | $ | (15,804,655) | | | | U.S. Federal Statutory Tax Rate | | | (3,318,978) | | 21.0 | % | State & Local Income Taxes, Net of Federal Income Tax Effect | | | 489,322 | | (3.1) | % | Foreign Tax Effects | | | — | | 0.0 | % | Change in Foreign Valuation Allowance | | | 10,218 | | (0.1) | % | Foreign Rate Differential | | | 6,948 | | 0.0 | % | Effect of Cross-Border Tax Laws | | | — | | 0.0 | % | Tax Credits | | | — | | 0.0 | % | Research and development tax credits | | | (80,482) | | 0.5 | % | Changes in Valuation Allowances | | | 2,567,925 | | (16.3) | % | Nontaxable or Nondeductible Items | | | — | | 0.0 | % | IRC 162(m) | | | 323,581 | | (2.0) | % | Other | | | 1,466 | | 0.0 | % | Changes in Unrecognized Tax Benefits | | | — | | 0.0 | % | Other Adjustments | | | — | | 0.0 | % | Effective Tax Rate | | $ | — | | 0.0 | % |
| | | | | | 2024 | Federal Statutory Rate | | $ | (1,893,000) | Permanent Differences | | | 208,000 | Research and Development | | | (180,000) | State Income Tax | | | (139,000) | State rate change | | | (397,000) | Change in Valuation Allowance | | | 2,253,000 | Deferred True Up | | | 148,000 | Effective Tax | | | — |
|
| Schedule of deferred tax assets and liabilities |
| | | | | | | | | 2025 | | 2024 | Intangible Assets | | $ | 67,540 | | $ | 60,277 | Accrued Expenses | | | 119,524 | | | 230,426 | Stock Based Compensation | | | 540,155 | | | 474,039 | Research & Development | | | 2,264,454 | | | 1,667,722 | Unrealized Exchange Gain/Loss | | | 3,482 | | | — | Net Operating Loss | | | 8,575,552 | | | 5,683,264 | Foreign Operating Loss | | | 10,218 | | | — | R&D Credits | | | 433,736 | | | 353,255 | Total gross deferred tax assets/(liabilities) | | $ | 12,014,660 | | $ | 8,468,983 | Less valuation allowance | | | (12,014,660) | | | (8,468,983) | Net deferred tax assets/(liabilities) | | $ | — | | $ | — |
|